{"BackgroundDespite": [0], "high": [1], "vaccine": [2, 44, 171], "coverage": [3], "and": [4, 68, 83, 150, 158, 232, 279], "effectiveness,": [5], "the": [6, 25, 36, 42, 63, 78, 102, 117, 124, 152, 156, 164, 169, 178, 256, 260], "incidence": [7, 27], "of": [8, 28, 38, 41, 65, 80, 87, 108, 168, 177, 193, 208, 221, 224, 244, 255, 259, 275], "symptomatic": [9], "infection": [10, 29], "with": [11, 97, 128, 141, 236, 282], "severe": [12], "acute": [13], "respiratory": [14], "syndrome": [15], "coronavirus": [16], "2": [17], "(SARS-CoV-2)": [18], "has": [19], "been": [20], "increasing": [21, 26], "in": [22, 101], "Israel.": [23], "Whether": [24], "is": [30, 45], "due": [31], "to": [32, 76, 84, 201, 216, 230, 250], "waning": [33], "immunity": [34], "after": [35, 175, 253], "receipt": [37, 167, 176, 254], "two": [39], "doses": [40], "BNT162b2": [43, 261], "unclear.MethodsWe": [46], "conducted": [47], "a": [48, 113, 129], "6-month": [49], "longitudinal": [50], "prospective": [51], "study": [52, 93], "involving": [53], "vaccinated": [54], "health": [55], "care": [56], "workers": [57], "who": [58], "were": [59, 74, 138, 184], "tested": [60], "monthly": [61], "for": [62, 123], "presence": [64], "anti-spike": [66], "IgG": [67, 109, 135, 157], "neutralizing": [69, 118, 142, 159, 181], "antibodies.": [70], "Linear": [71], "mixed": [72], "models": [73], "used": [75], "assess": [77], "dynamics": [79], "antibody": [81, 88, 119, 136, 143, 160, 182], "levels": [82, 89, 137, 161], "determine": [85], "predictors": [86], "at": [90, 112], "6": [91], "months.ResultsThe": [92], "included": [94, 100], "4868": [95], "participants,": [96], "3808": [98], "being": [99], "linear": [103], "mixed-model": [104], "analyses.": [105], "The": [106], "level": [107, 120], "antibodies": [110], "decreased": [111, 121], "consistent": [114], "rate,": [115], "whereas": [116], "rapidly": [122], "first": [125], "3": [126], "months": [127, 174, 252], "relatively": [130], "slow": [131], "decrease": [132], "thereafter.": [133], "Although": [134], "highly": [139], "correlated": [140], "titers": [144, 183], "(Spearman's": [145], "rank": [146], "correlation": [147], "between": [148, 155], "0.68": [149], "0.75),": [151, 202], "regression": [153], "relationship": [154], "depended": [162], "on": [163], "time": [165], "since": [166], "second": [170, 179, 257], "dose.": [172], "Six": [173], "dose,": [180], "substantially": [185, 266], "lower": [186, 203, 233], "among": [187, 190, 204, 213, 234, 239, 269, 271, 280], "men": [188], "than": [189, 212, 218, 238], "women": [191], "(ratio": [192, 223, 243], "means,": [194, 225, 245], "0.64;": [195], "95%": [196, 227, 247], "confidence": [197], "interval": [198], "[CI],": [199], "0.55": [200], "persons": [205, 272, 281], "65": [206, 273], "years": [207, 220, 274], "age": [209, 222, 276], "or": [210, 277], "older": [211], "those": [214, 240], "18": [215], "less": [217], "45": [219], "0.58;": [226], "CI,": [228, 248], "0.48": [229], "0.70),": [231], "participants": [235], "immunosuppression": [237, 242], "without": [241], "0.30;": [246], "0.20": [249], "0.46).ConclusionsSix": [251], "dose": [258], "vaccine,": [262], "humoral": [263], "response": [264], "was": [265], "decreased,": [267], "especially": [268], "men,": [270], "older,": [278], "immunosuppression.": [283]}